Norovirus-glycan interactions - how strong are they really?


Journal

Biochemical Society transactions
ISSN: 1470-8752
Titre abrégé: Biochem Soc Trans
Pays: England
ID NLM: 7506897

Informations de publication

Date de publication:
28 02 2022
Historique:
received: 02 11 2021
revised: 01 12 2021
accepted: 06 12 2021
pubmed: 24 12 2021
medline: 20 4 2022
entrez: 23 12 2021
Statut: ppublish

Résumé

Infection with human noroviruses requires attachment to histo blood group antigens (HBGAs) via the major capsid protein VP1 as a primary step. Several crystal structures of VP1 protruding domain dimers, so called P-dimers, complexed with different HBGAs have been solved to atomic resolution. Corresponding binding affinities have been determined for HBGAs and other glycans exploiting different biophysical techniques, with mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy being most widely used. However, reported binding affinities are inconsistent. At the extreme, for the same system MS detects binding whereas NMR spectroscopy does not, suggesting a fundamental source of error. In this short essay, we will explain the reason for the observed differences and compile reliable and reproducible binding affinities. We will then highlight how a combination of MS techniques and NMR experiments affords unique insights into the process of HBGA binding by norovirus capsid proteins.

Identifiants

pubmed: 34940787
pii: 230564
doi: 10.1042/BST20210526
pmc: PMC9022987
doi:

Substances chimiques

Blood Group Antigens 0
Capsid Proteins 0
Polysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-359

Informations de copyright

© 2022 The Author(s).

Références

Glycobiology. 2018 Jul 1;28(7):488-498
pubmed: 29562255
J Am Chem Soc. 2001 Jun 27;123(25):6108-17
pubmed: 11414845
Glycobiology. 2015 Feb;25(2):170-80
pubmed: 25395406
J Phys Chem B. 2015 Sep 3;119(35):11466-72
pubmed: 26260011
Viruses. 2021 Mar 05;13(3):
pubmed: 33807801
Structure. 2011 Sep 7;19(9):1274-82
pubmed: 21893287
Glycobiology. 2017 Jan;27(1):80-86
pubmed: 27496762
J Virol. 2012 Jan;86(1):284-92
pubmed: 22031945
Analyst. 2017 Aug 7;142(16):2874-2886
pubmed: 28702519
J Struct Biol. 2012 Feb;177(2):273-82
pubmed: 22266117
J Virol. 2007 Jun;81(11):5949-57
pubmed: 17392366
J Am Chem Soc. 2019 Oct 16;141(41):16303-16311
pubmed: 31533424
Curr Opin Struct Biol. 2020 Jun;62:22-30
pubmed: 31835069
mSphere. 2016 Mar 30;1(2):
pubmed: 27303720
Gastroenterology. 2002 Jun;122(7):1967-77
pubmed: 12055602
Chem Soc Rev. 2011 Mar;40(3):1224-34
pubmed: 21173980
PLoS Pathog. 2011 Jul;7(7):e1002152
pubmed: 21811409
J Virol. 2009 May;83(9):4092-101
pubmed: 19244326
Angew Chem Int Ed Engl. 2012 Jan 23;51(4):928-32
pubmed: 22170811
PLoS Med. 2016 Apr 26;13(4):e1001999
pubmed: 27115709
J Am Chem Soc. 2014 Sep 10;136(36):12631-7
pubmed: 25105447
ACS Omega. 2019 Aug 19;4(9):13618-13630
pubmed: 31497679
Anal Chem. 2003 Oct 1;75(19):4945-55
pubmed: 14708765
J Virol. 2012 May;86(10):5584-93
pubmed: 22438544
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12366-71
pubmed: 9356455
Prog Nucl Magn Reson Spectrosc. 2013 Aug;73:1-16
pubmed: 23962882
Glycobiology. 2009 Nov;19(11):1176-84
pubmed: 19625485
Glycobiology. 2017 Nov 1;27(11):1027-1037
pubmed: 28973640
J Phys Condens Matter. 2018 Feb 14;30(6):064006
pubmed: 29282349
J Gen Virol. 2019 Oct;100(10):1393-1406
pubmed: 31483239
Molecules. 2021 Apr 07;26(8):
pubmed: 33917179
Commun Biol. 2022 May 23;5(1):488
pubmed: 35606511
Vaccines (Basel). 2020 Dec 24;9(1):
pubmed: 33374273
Virology. 2015 Sep;483:203-8
pubmed: 25980740
Curr Opin Chem Biol. 2004 Dec;8(6):617-25
pubmed: 15556405
J Am Soc Mass Spectrom. 2008 Mar;19(3):332-43
pubmed: 18083584
Biomacromolecules. 2018 Sep 10;19(9):3714-3724
pubmed: 30071731
Adv Virus Res. 2019;105:189-238
pubmed: 31522705
J Infect Dis. 2003 Jul 1;188(1):19-31
pubmed: 12825167
PLoS One. 2009;4(4):e5058
pubmed: 19337380
J Biol Chem. 2020 Nov 20;295(47):15974-15987
pubmed: 32913124
Glycobiology. 2013 Mar;23(3):276-85
pubmed: 23118206
Chemistry. 2010 Jul 12;16(26):7803-12
pubmed: 20496354
Nat Commun. 2019 Mar 21;10(1):1320
pubmed: 30899001
Vox Sang. 1989;56(1):1-20
pubmed: 2464874
Annu Rev Biochem. 2004;73:107-46
pubmed: 15189138
J Virol. 2011 Jul;85(13):6687-701
pubmed: 21525337
J Virol. 2008 Jun;82(11):5340-7
pubmed: 18385236
Angew Chem Int Ed Engl. 2003 Feb 24;42(8):864-90
pubmed: 12596167
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788
pubmed: 29711196
J Virol. 2015 Feb;89(4):2024-40
pubmed: 25428879
Nat Rev Drug Discov. 2009 Aug;8(8):661-77
pubmed: 19629075
Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12014-9
pubmed: 26329854
Angew Chem Int Ed Engl. 2017 Nov 27;56(48):15289-15293
pubmed: 28977722
ACS Chem Biol. 2017 May 19;12(5):1288-1296
pubmed: 28294600
Life (Basel). 2021 Jun 11;11(6):
pubmed: 34208397
Anal Chem. 2006 May 1;78(9):3010-8
pubmed: 16642987
Viruses. 2010 Apr;2(4):1011-49
pubmed: 21994669
Angew Chem Int Ed Engl. 2016 Nov 2;55(45):14173-14176
pubmed: 27545682

Auteurs

Thomas Peters (T)

Institute of Chemistry and Metabolomics, University of Lübeck, 23562 Lübeck, Germany.

Robert Creutznacher (R)

Institute of Chemistry and Metabolomics, University of Lübeck, 23562 Lübeck, Germany.

Thorben Maass (T)

Institute of Chemistry and Metabolomics, University of Lübeck, 23562 Lübeck, Germany.

Alvaro Mallagaray (A)

Institute of Chemistry and Metabolomics, University of Lübeck, 23562 Lübeck, Germany.

Patrick Ogrissek (P)

Institute of Chemistry and Metabolomics, University of Lübeck, 23562 Lübeck, Germany.

Stefan Taube (S)

Institute of Virology and Cell Biology, University of Lübeck, 23562 Lübeck, Germany.

Lars Thiede (L)

Centre for Structural Systems Biology (CSSB), 22607 Hamburg & Leibniz Institute for Experimental Virology (HPI), 20251 Hamburg, Germany.

Charlotte Uetrecht (C)

Centre for Structural Systems Biology (CSSB), 22607 Hamburg & Leibniz Institute for Experimental Virology (HPI), 20251 Hamburg, Germany.
School of Life Sciences, University of Siegen, 57076 Siegen & Deutsches Elektronensynchrotron (DESY), 22607 Hamburg & European XFEL GmbH, 22869 Schenefeld, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH